QA: Arvinas INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001655759_2024_Arvinas_INC.pdf

Logs

Graph

Absolute values for 0001655759, Arvinas INC

  xvar xval
0 AssetsCurrent 1,280,200,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 11,500,000
3 remainder_Assets 12,900,000
4 LiabilitiesCurrent 257,100,000
5 LiabilitiesNoncurrent 387,500,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 203,583,694
9 ResearchAndDevelopmentExpense 580,690,094
10 remainder_Expenses 18,527,883
11 remainder_Revenues 91,798,339
12 remainder_NetIncome 20,461,500
13 remainder_ComprehensiveNetIncome -14,431,862
  yvar yval
0 Assets 1,304,600,000
1 Liabilities 644,600,000
2 Expenses 802,801,671
3 Revenues 91,798,339
4 StockholdersEquity 660,000,000
5 NetIncome -690,541,832
6 ComprehensiveNetIncome -697,757,763
7 BaseVar 1,439,346,686
8 EconomicCapitalRatiobeforeLimitedLiability 0.760
9 EconomicCapitalRatio 2.11

Edgar->Model Mapping

Feature Distribution

Change over Time